Teckro is a life science technology company that is rethinking every element of clinical research.
Teckro has raised $25.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2021.
Teckro's investors include Founders Fund, Sands Capital Ventures, Enterprise Ireland, S32, Borealis Ventures.
Teckro is headquartered in New York, United States.
Teckro is a life science technology company that is rethinking every element of clinical research.
Teckro is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Teckro — Funding & Investors." VCBacked, November 24, 2021, https://www.vcbacked.co/company/teckro. Accessed November 12, 2026.
VCBacked. (2021). Teckro — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/teckro
{{cite web |title=Teckro — Funding & Investors |url=https://www.vcbacked.co/company/teckro |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Teckro? Request a listing update